Zimmerer Jason M, Chaudhari Sachi, Koneru Kavya, Han Jing L, Abdel-Rasoul Mahmoud, Uwase Hope, Yi Tai, Breuer Christopher K, Bumgardner Ginny L
Department of Surgery, Comprehensive Transplant Center, and the College of Medicine, The Ohio State University, Columbus, OH.
Biomedical Sciences Graduate Program, The Ohio State University College of Medicine, Columbus, OH.
Transplant Direct. 2025 Jan 9;11(2):e1742. doi: 10.1097/TXD.0000000000001742. eCollection 2025 Feb.
Alloprimed antibody-suppressor CXCR5CD8 T cells (CD8 T cells) downregulate alloantibody production, mediate cytotoxicity of IgG B cells, and prolong allograft survival. The purpose of this investigation was to determine which immune-cell subsets are susceptible to CD8 T cell-mediated cytotoxicity or noncytotoxic suppression.
Alloprimed immune-cell subsets were evaluated for susceptibility to CD8 T cell-mediated in vitro cytotoxicity and/or suppression of intracellular cytokine expression. In vivo CD8-mediated cytotoxicity to wild-type germinal center (GC) B cells or wild-type CD4 T follicular helper cells (T cells) was assessed in RAG1 knockout mice. The impact of in vivo adoptive transfer of CD8 T cells into hepatocyte or kidney transplant recipients on the quantity of lymphoid immune-cell subsets was assessed.
CD8 T cells mediated allospecific cytotoxicity to alloprimed GC B cells but not alloprimed extrafollicular plasmablasts, marginal zone B cells, follicular B cells, or plasma cells. CD8 T cells did not mediate cytotoxicity to alloprimed dendritic cells, macrophages, CD4 T cells, CD4 T follicular regulatory cells, or CD4 regulatory T cell. CD8 T cells did not suppress CD4 T cell, T follicular regulatory cell, or regulatory T-cell cytokine expression. Adoptive transfer of CD8 T cells into hepatocyte or kidney transplant recipients reduced alloantibody production and the quantity of GC B cells, T cells, and plasma cells (but not other B-cell, T-cell, or antigen-presenting cell subsets). The reduction of T-cell quantity was dependent on CD8 T cell-mediated major histocompatibility complex-I-dependent cytotoxic killing of GC B cells.
The primary targets of CD8 T cells are GC B cells with downstream reduction of T and plasma cells.
同种异体致敏抗体抑制性CXCR5 CD8 T细胞(CD8 T细胞)可下调同种异体抗体产生,介导IgG B细胞的细胞毒性,并延长同种异体移植物存活时间。本研究的目的是确定哪些免疫细胞亚群易受CD8 T细胞介导的细胞毒性或非细胞毒性抑制作用影响。
评估同种异体致敏免疫细胞亚群对CD8 T细胞介导的体外细胞毒性和/或细胞内细胞因子表达抑制的易感性。在RAG1基因敲除小鼠中评估体内CD8介导的对野生型生发中心(GC)B细胞或野生型CD4滤泡辅助性T细胞(T细胞)的细胞毒性。评估将CD8 T细胞体内过继转移至肝细胞或肾移植受者对淋巴免疫细胞亚群数量的影响。
CD8 T细胞介导对同种异体致敏GC B细胞的同种异体特异性细胞毒性,但对同种异体致敏的滤泡外浆母细胞、边缘区B细胞、滤泡B细胞或浆细胞无此作用。CD8 T细胞对同种异体致敏的树突状细胞、巨噬细胞、CD4 T细胞、CD4滤泡调节性T细胞或CD4调节性T细胞不介导细胞毒性。CD8 T细胞不抑制CD-4 T细胞、滤泡调节性T细胞或调节性T细胞的细胞因子表达。将CD8 T细胞过继转移至肝细胞或肾移植受者可减少同种异体抗体产生以及GC B细胞、T细胞和浆细胞的数量(但不影响其他B细胞、T细胞或抗原呈递细胞亚群)。T细胞数量的减少依赖于CD8 T细胞介导的主要组织相容性复合体-I依赖性GC B细胞的细胞毒性杀伤作用。
CD8 T细胞的主要靶细胞是GC B细胞,其下游效应是T细胞和浆细胞数量减少。